Media Coverage
September 29, 2025
2025
2025

BillionToOne Sees Future for In Utero Cystic Fibrosis Treatment Guided by NIPT Risk Screening

Share this post
Copy URL

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

LinkedIn
X

News & Media

Press Releases
November 5, 2025
BillionToOne Announces Pricing of Upsized Initial Public Offering
Read Article
Press Releases
October 29, 2025
BillionToOne Announces Launch of Initial Public Offering Roadshow
Read Article
Media Coverage
October 28, 2025
BillionToOne targeting around $211M in IPO
Read Article
Media Coverage
October 26, 2025
MapLight Therapeutics defies government shutdown with IPO that raises more than $250 million
Read Article
Media Coverage
October 17, 2025
BillionToOne's Path to a $2B+ Valuation: Strategic IPO Positioning in a High-Growth Market
Read Article
Media Coverage
October 17, 2025
BillionToOne targets over $2 billion valuation in US IPO
Read Article
Press Releases
October 10, 2025
New Study Showed Unnecessary Burden From Continued Monitoring of Alloimmunized Pregnancies With Antigen-Negative Fetuses
Read Article
Media Coverage
October 9, 2025
Endpoints HealthTech
Read Article
Media Coverage
October 8, 2025
MapLight Taps Workaround for IPO Despite Government Shutdown
Read Article
Media Coverage
October 8, 2025
BillionToOne files for IPO with a special offering for a biotech: Actual revenue
Read Article
Media Coverage
October 8, 2025
BillionToOne Files for IPO
Read Article
Media Coverage
October 7, 2025
Molecular diagnostics firm BillionToOne files for US IPO
Read Article